홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → (1R,2S)-5'-methoxy-2-(3-(4-(4-methylpiperazin-1-yl)phenyl)-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-one hydrochloride

HRID 1410361
인쇄

반응식

HRID 1410361 반응식
IC1C2C(=CC([C@H]3[C@@]4(C5C(=CC=C(OC)C=5)NC4=O)C3)=CC=2)NN=1.CN1CCN(C2C=CC(B3OC(C)(C)C(C)(C)O3)=CC=2)CC1.[Li+].[Cl-:48].C([O-])([O-])=O.[Na+].[Na+].[I-].Cl.[CH3:57][O:58][C:59]1[CH:60]=[C:61]2[C:65](=[CH:66][CH:67]=1)[NH:64][C:63](=[O:68])[C@:62]12[CH2:70][C@H:69]1[C:71]1[CH:79]=[C:78]2[C:74]([C:75]([C:80]3[CH:85]=[CH:84][C:83]([N:86]4[CH2:91][CH2:90][N:89]([CH3:92])[CH2:88][CH2:87]4)=[CH:82][CH:81]=3)=[N:76][NH:77]2)=[CH:73][CH:72]=1>O1CCOCC1.C1COCC1.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[ClH:48].[CH3:57][O:58][C:59]1[CH:60]=[C:61]2[C:65](=[CH:66][CH:67]=1)[NH:64][C:63](=[O:68])[C@:62]12[CH2:70][C@H:69]1[C:71]1[CH:79]=[C:78]2[C:74]([C:75]([C:80]3[CH:81]=[CH:82][C:83]([N:86]4[CH2:87][CH2:88][N:89]([CH3:92])[CH2:90][CH2:91]4)=[CH:84][CH:85]=3)=[N:76][NH:77]2)=[CH:73][CH:72]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

11

반응물 7

HCID 313Hydrochloric AcidHCID 10340Sodium CarbonateHCID 30165Iodide IonHCID 433294Lithium ChlorideHCID 179989051-Methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazineHCID 58486186(1R,2S)-5'-methoxy-2-(3-(4-(4-methylpiperazin-1-yl)phenyl)-1H-indazol-6-yl)spiro [cyclopropane-1,3'-indolin]-2'-one
HCID 178487035HCID 178487035, 화합물

생성물 1

HCID 67445846(1R,2S)-5'-methoxy-2-(3-(4-(4-methylpiperazin-1-yl)phenyl)-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-one hydrochloride수율 99.2%

시약·촉매·용매 3

HCID 178418397HCID 178418397, 화합물촉매HCID 8028Tetrahydrofuran용매HCID 312751,4-Dioxane용매

실험 절차

A mixture of (1R,2S)-2-(3-iodo-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (Example 4C, 540 mg, 1.25 mmol), 1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine (416 mg, 1.38 mmol), Pd(PPh3)4 (7 mg, 0.06 mmol), LiCl (159 mg, 3.75 mmol) and 1M Na2CO3 (6.3 mL, 6.3 mmol) in dioxane (20 mL) was heated to reflux in an oil bath until the iodide had been consumed as determined by LCMS. The reaction was then allowed to cool to room temperature and was diluted with EtOAc and water was added. The resulting mixture was extracted with EtOAc and the combined organic extracts were washed with brine, dried over MgSO4 and concentrated to give an orange solid. The title compound was purified by silica gel chromatography (95:3:2 to 85:13:2 CH2Cl2/MeOH/NH3) to yield a yellow solid. HCl (1M in diethyl ether, 3.1 mL, 3.1 mmol) was added in a dropwise manner to a solution of (1R,2S)-5′-methoxy-2-(3-(4-(4-methylpiperazin-1-yl)phenyl)-1H-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (240 mg, 0.500 mmol) in THF (1 mL). A yellow precipitate formed and the solid was then filtered and washed with ether (2 mL) giving the title compound (256 mg, 42%, HCl salt). 1H NMR (400 MHz, CD3OD) δ 7.94 (d, J=8.2 Hz, 1H), 7.88 (d, J=8.4 Hz, 2H), 7.52 (s, 1H), 7.19 (d, J=8.6 Hz, 2H), 7.05 (d, J=8.2 Hz, 1H), 6.84 (d, J=8.4 Hz, 1H), 6.62 (d, J=7.7 Hz, 1H), 5.62 (s, 1H), 4.01-3.98 (m, 2H), 3.67-3.64 (m, 2H), 3.39-3.32 (m, 3H), 3.28 (s, 3H), 3.18-3.11 (m, 2H), 3.00 (s, 3H), 2.28-2.25 (m, 1H), 2.21-2.18 (m, 1H); MS ESI 480.4 [M+H]+, calcd for [C29H29N5O2+H]+ 480.23. Optical Rotation: [α]22D=−126° (c 0.40, MeOH).

후처리

  1. temperaturewas heated
  2. customhad been consumed
  3. additionwas diluted with EtOAc and water
  4. additionwas added
  5. extractionThe resulting mixture was extracted with EtOAc
  6. washthe combined organic extracts were washed with brine
  7. dry with materialdried over MgSO4
  8. concentrationconcentrated
  9. customto give an orange solid
  10. customThe title compound was purified by silica gel chromatography (95:3:2 to 85:13:2 CH2Cl2/MeOH/NH3)
  11. customto yield a yellow solid
  12. customA yellow precipitate formed
  13. filtrationthe solid was then filtered
  14. washwashed with ether (2 mL)

출처 및 근거

ORD 기록
ord-a882fd9444f1454fbb70d7b1693a3f42
출처 데이터셋
uspto-grants-2014_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08921545B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트